VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up
The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
technologynetworks21h
US Approves Non-Opioid Painkiller: What Is It, and How Does It Work?
The US Food and Drug Administration (FDA) announced its approval of a non-opioid treatment for moderate–severe acute chronic ...
Nursing in Practice1d
CPD: Preventing diabetes complications
GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures ...